DAPI Fluoromount-G®

Mutated FSHR transfected COS-7 cells were stained with anti-FSH-receptor followed by an AF555 conjugated secondary antibody and mounted with DAPI Fluoromount-G® (SB Cat. No. 0100-20). Image from Hugon-Rodin J, Sonigo C, Gompel A, Dodé C, Grynberg M, Binart N, et al. First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome. BMC Med Genet. 2017;18:44. Figure 3(d)

Human cancer-associated fibroblasts 120 h post exposure to 18 Gy were stained with anti-vinculin followed by an AF488 conjugated secondary antibody and mounted with DAPI Fluoromount-G® (SB Cat. No. 0100-20). Image from Hellevik T, Pettersen I, Berg V, Winberg JO, Moe BT, Bartnes K, et al. Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced. Radiat Oncol. 2012;7:59. Figure 6(a)

Human cancer-associated fibroblasts 120 h post exposure to 18 Gy were stained with anti-53BP1 followed by an AF546 conjugated secondary antibody and mounted with DAPI Fluoromount-G® (SB Cat. No. 0100-20). Image from Hellevik T, Pettersen I, Berg V, Winberg JO, Moe BT, Bartnes K, et al. Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced. Radiat Oncol. 2012;7:59. Figure 1(c)